Explore our materials

Filters

Results (5576)

International Workshop on HIV Transmission 2016

Research update: drug development - Myron Cohen, MD

International Workshop on HIV Transmission 2016

The Role of TAF in PrEP - Katy Garrett, PharmD

International Workshop on HIV Transmission 2016

Studies in early acute infection and implications for transmission and cure - Merlin Robb, MD

International Workshop on HIV Transmission 2016

The fine specificity and autologous virus neutralization potency of maternal antibodies that predict reduced HIV-1 mother to child transmission - Sallie Permar, MD, PhD

International Workshop on HIV Transmission 2016

Study of early development of broadly neutralizing antibodies in HIV-1-infected infants - Cassandra Simonich, MD/PhD Candidate

HIV DART and Emerging Viruses 2016

Collateral Damage with Antiviral Therapy | David Thomas, MD, MPH

Scott Letendre

MD

HIV DART and Emerging Viruses 2016

Management of Neurocognitive Impairment of Aging Populations Living with HIV | Scott Letendre, MD

HIV DART and Emerging Viruses 2016

(Abstract) Antiviral Activity of tenofovir alafenamide against HIV-1 with thymidine analog mutation(s) and M184V | C. Callebaut

HIV DART and Emerging Viruses 2016

(Abstract) Development of a protease inhibitor-based single-tablet complete HIV-1 regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (DCFTAF) | B. Baugh

Mark Wainberg

MD

HIV DART and Emerging Viruses 2016

Gertrude Elion Distinguished Lecturer Award Lecture Stories on Scientific Discoveries that Transformed HIV into a Manageable Disease | Mark Wainberg, MD

HIV DART and Emerging Viruses 2016

(Abstract) Anti–HIV drug candidate abx464 prevents intestinal inflammation by producing IL22 in activated macrophages | J. Tazi

HIV DART and Emerging Viruses 2016

Current Clinical Therapies for HIV Remission | David Margolis, MD